Blue Zone Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-890
Closed -$205K 82
2020
Q4
$205K Sell
890
-288
-24% -$66.4K 0.1% 72
2020
Q3
$299K Hold
1,178
0.17% 61
2020
Q2
$278K Sell
1,178
-50
-4% -$11.4K 0.16% 56
2020
Q1
$249K Buy
1,228
+32
+3% +$6.99K 0.23% 42
2019
Q4
$288K Buy
+1,196
New +$264K 0.19% 40

Other funds holding AMGN

Blue Zone Wealth Advisors's AMGN Position: Q1 2021 in Review

Blue Zone Wealth Advisors sold out of Amgen (AMGN) in Q1 2021, closing a stake of 890 shares — an estimated $205K sold.

Blue Zone Wealth Advisors first reported a position in AMGN in Q4 2019 and held it in 5 quarters. The position peaked at $299K in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • Blue Zone Wealth Advisors reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
  • Blue Zone Wealth Advisors sold 890 Amgen shares in Q1 2021, an estimated $205K.
  • Blue Zone Wealth Advisors first reported a position in Amgen in Q4 2019 and held it in 5 quarters.
  • Blue Zone Wealth Advisors's Amgen position peaked at $299K in Q3 2020.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Blue Zone Wealth Advisors's 13F filing for Q1 2021, filed 4 May 2021.